Alcon (ALC) EPS (Diluted) Growth (1y) (2010 - 2025)
Analysis
Alcon (ALC) EPS (Diluted) Growth (1y) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -47.60% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 26.30% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 41.58% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 44.49% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 15.24% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -25.88% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 44.97% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 13.96% |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | 33.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.69% |
| Sep 30, 2025 | -2.19% |
| Jun 30, 2025 | -21.23% |
| Dec 31, 2024 | 493.71% |
| Sep 30, 2024 | 47.17% |
| Jun 30, 2024 | -13.60% |
| Mar 31, 2024 | 52.92% |
| Dec 31, 2023 | -358.90% |
| Sep 30, 2023 | 52.50% |
| Jun 30, 2023 | 75.67% |
| Mar 31, 2023 | 8.40% |
| Dec 31, 2022 | -75.57% |
| Sep 30, 2022 | 467.53% |
| Jun 30, 2022 | -37.36% |
| Mar 31, 2022 | 71.59% |
| Dec 31, 2021 | -96.13% |
| Sep 30, 2021 | 74.64% |
| Jun 30, 2021 | 139.63% |
| Mar 31, 2021 | 265.16% |
| Dec 31, 2020 | 23.49% |